A Multicentre Trial of the Aldose-Reductase Inhibitor, Tolrestat, in Patients With Symptomatic Diabetic Neuropathy

Diabetologia - Germany
doi 10.1007/bf00404095
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy